Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis.

Academic Medical Centre, Department of Cardiology, PO Box 22660, 1100 DD Amsterdam, The Netherlands.
Neurology (Impact Factor: 8.3). 02/2009; 72(7):635-42. DOI: 10.1212/01.wnl.0000342471.07290.07
Source: PubMed

ABSTRACT Impact of cardiac complications after aneurysmal subarachnoid hemorrhage (SAH) remains controversial. We performed a meta-analysis to assess whether EKG changes, myocardial damage, or echocardiographic wall motion abnormalities (WMAs) are related to death, poor outcome (death or dependency), or delayed cerebral ischemia (DCI) after SAH.
Articles on cardiac abnormalities after aneurysmal SAH that met predefined criteria and were published between 1960 and 2007 were retrieved. We assessed the quality of reports and extracted data on patient characteristics, cardiac abnormalities, and outcome measurements. Poor outcome was defined as death or dependence by the Glasgow Outcome Scale (dichotomized at < or = 3) or the modified Rankin scale (dichotomized at > 3). If studies used another dichotomy or another outcome scale, we used the numbers of patients with poor outcome provided by the authors. We calculated pooled relative risks (RRs) with corresponding 95% confidence intervals for the relation between cardiac abnormalities and outcome measurements.
We included 25 studies (16 prospective) with a total of 2,690 patients (mean age 53 years; 35% men). Mortality was associated with WMAs (RR 1.9), elevated troponin (RR 2.0) and brain natriuretic peptide (BNP) levels (RR 11.1), tachycardia (RR 3.9), Q waves (RR 2.9), ST-segment depression (RR 2.1), T-wave abnormalities (RR 1.8), and bradycardia (RR 0.6). Poor outcome was associated with elevated troponin (RR 2.3) and creatine kinase MB (CK-MB) levels (RR 2.3) and ST-segment depression (RR 2.4). Occurrence of DCI was associated with WMAs (RR 2.1), elevated troponin (RR 3.2), CK-MB (RR 2.9), and BNP levels (RR 4.5), and ST-segment depression (RR 2.4). All RRs were significant.
Markers for cardiac damage and dysfunction are associated with an increased risk of death, poor outcome, and delayed cerebral ischemia after subarachnoid hemorrhage. Future research should establish whether these cardiac abnormalities are independent prognosticators and should be directed toward pathophysiologic mechanisms and potential treatment options.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients suffering from aneurysmal subarachnoid hemorrhage often present with electrocardiogram (ECG) abnormalities that mimic cardiac ischemia, but documented left ventricular regional wall-motion dysfunction has rarely been reported. This report is intended to raise the awareness of possible ECG changes secondary to subarachnoid hemorrhage (SAH). We cared for a 55-year-old female with an acute aneurysmal subarachnoid hemorrhage, whose evaluation was delayed and complicated by the presence of Takotsubo cardiomyopathy (TCM). Aneurysmal subarachnoid hemorrhage may induce Takotsubo cardiomyopathy that can present as an acute ST-elevation myocardial infarction. Physicians need to be aware of this possibility since it can lead to significant delays and treatment options for the patient.
    International Journal of Emergency Medicine 01/2014; 7:33.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neurogenic stress cardiomyopathy (NCM) has been associated with poor outcomes in the setting of aneurysmal subarachnoid hemorrhage (aSAH). Much less is known regarding recovery of cardiac function. The aim of this prospective cohort study was to study the rate of early cardiac recovery after NCM and the potential effect of NCM on short term functional recovery. A secondary aim sought to determine whether certain biomarkers may be associated with the development of NCM.Methods Patients with confirmed aSAH between November 2012 and October 2013 were prospectively enrolled and received echocardiograms within 48 h of admission. Ejection fraction (%) and regional wall motion abnormality score index (RWMI) were noted. All patients with confirmed aSAH had a troponin and BNP level drawn on admission. Patients with confirmed NCM received a follow up echocardiogram 7–21 days after the initial echocardiogram. Clinical follow up at 3 months evaluated mortality, mRS and mBI scores.Results63 patients with confirmed aSAH were enrolled. In this cohort 11 (17%) patients were confirmed to have NCM. The NCM group had higher in-hospital mortality [n = 4(36.4%)] compared to the non-NCM group [n = 5(9.6%)] (p = .021). At 3 months the development of NCM was associated with an unfavorable mRS (p = 0.042) and mBI (p = 0.005). Both an elevated BNP (>100 pg/mL) and elevated troponin (>0.3 mg/dL) were associated with the development of NCM. Follow-up echocardiograms were performed within 21 days of admission on 8 patients with NCM. An abnormal RWMI of 1.5 or higher was present in 5(71%) patients.ConclusionNCM is a frequent complication associated with aSAH. The onset of the disease occurs early in the course of aSAH and an elevated BNP and troponin may be associated with the onset of NCM. Cardiac function often remains impaired during the acute recovery phase potentially impeding resuscitation during this period. The routine use of short term follow-up echocardiography may be recommended.
    Clinical Neurology and Neurosurgery 11/2014; · 1.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A pesar de que la mayoría de los aneurismas cerebrales son asintomáticos y se describen incidentalmente, su ruptura suele resultar en una morbimortalidad significativa Por lo tanto, el anestesiólogo pudiera intervenir realizando un clipaje quirúrgico del aneurisma, bien sea de manera electiva o posterior a una hemorragia subaracnoidea. Luego de una hemorragia subaracnoidea es indispensable hacer una evaluación preoperatoria sistémica porque el manejo anestésico puede verse afectado tanto por las complicaciones neurológicas (presión intracraneal elevada, repetición de la hemorragia, hidrocefalia, vasoespasmo) y complicaciones no neurológicas (insuficiencia respiratoria, disfunción cardíaca, anomalías electrolíticas, alteraciones endocrinas). Además de estar preparado para una hemorragia profusa súbita, el anestesiólogo a cargo de una craneotomía para clipaje de un aneurisma debe adherirse a 4 principios fundamentales. Primero, debe evitarse el incremento agudo en el gradiente transmural del aneurisma (presión arterial media menos la presión intracraneal) para impedir una ruptura o recurrencia de hemorragia. Segundo, la presión de perfusión cerebral debe mantenerse con euvolemia y vasopresores para evitar isquemia cerebral, bien sea con separadores cerebrales o clipaje temporal del vaso nutriente. Tercero, debe optimizarse la exposición quirúrgica con relajación cerebral mediante oxigenación y ventilación cerebral normal, selección apropiada del anestésico, manitol y tal vez lasix, drenaje de líquido cefalorraquídeo o hiperventilación transitoria. Cuarto, se recomienda el despertar temprano de la anestesia para reconocer precozmente las complicaciones potencialmente reversibles. Siendo vigilante y logrando estas metas, el anestesiólogo contribuirá al logro de desenlaces óptimos para el paciente.El siguiente artículo ofrece información para orientar al anestesiólogo para el óptimo manejo del clipaje quirúrgico de aneurismas.
    Revista Colombiana de Anestesiologia 10/2014; 43.


Available from
Jun 10, 2014